E J Schenkel

Summary

Publications

  1. ncbi Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray
    E J Schenkel
    Valley Clinical Research Center, Easton, Pennsylvania 18045, USA
    Pediatrics 105:E22. 2000
  2. ncbi Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis
    Eric Schenkel
    Valley Allergy and Asthma Treatment Center Valley Clinical Research Center, Easton, PA, USA
    Expert Opin Pharmacother 4:1579-91. 2003
  3. ncbi Effect of desloratadine on the control of morning symptoms in patients with seasonal and perennial allergic rhinitis
    Eric J Schenkel
    Valley Allergy and Asthma Treatment Center Valley Clinical Research Center, 3729 Easton Nazareth Highway, Suite 202, Easton, PA 18045, USA
    Allergy Asthma Proc 27:465-72. 2006
  4. ncbi Combining desloratadine and pseudoephedrine in the treatment of seasonal allergic rhinitis
    Eric J Schenkel
    Valley Clinical Research Center, 3729 Easton Nazareth Highway, Suite 202, Easton, PA 18045, USA
    Expert Rev Clin Immunol 2:519-31. 2006
  5. ncbi Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion
    William E Berger
    Southern California Research, Mission Viejo, California 92691, USA
    Ann Allergy Asthma Immunol 89:485-91. 2002
  6. ncbi Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis
    Nancy C Santanello
    Merck Research Laboratories, Rahway, New Jersey, USA
    Allergy Asthma Proc 27:231-9. 2006

Detail Information

Publications6

  1. ncbi Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray
    E J Schenkel
    Valley Clinical Research Center, Easton, Pennsylvania 18045, USA
    Pediatrics 105:E22. 2000
    ....
  2. ncbi Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis
    Eric Schenkel
    Valley Allergy and Asthma Treatment Center Valley Clinical Research Center, Easton, PA, USA
    Expert Opin Pharmacother 4:1579-91. 2003
    ..Studies demonstrate that mometasone furoate NS is a potent, clinically effective and well-tolerated intranasal corticosteroid with negligible systemic activity and which offers the convenience of once-daily dosing...
  3. ncbi Effect of desloratadine on the control of morning symptoms in patients with seasonal and perennial allergic rhinitis
    Eric J Schenkel
    Valley Allergy and Asthma Treatment Center Valley Clinical Research Center, 3729 Easton Nazareth Highway, Suite 202, Easton, PA 18045, USA
    Allergy Asthma Proc 27:465-72. 2006
    ..The sustained 24-hour action of desloratadine and its effective control of morning symptoms make it a valuable tool for improving the quality of life of patients with allergic rhinitis...
  4. ncbi Combining desloratadine and pseudoephedrine in the treatment of seasonal allergic rhinitis
    Eric J Schenkel
    Valley Clinical Research Center, 3729 Easton Nazareth Highway, Suite 202, Easton, PA 18045, USA
    Expert Rev Clin Immunol 2:519-31. 2006
    ..This drug profile reviews a combination therapy containing desloratadine and pseudoephedrine, approved in the USA for the relief of the symptoms of seasonal allergic rhinitis, including nasal congestion...
  5. ncbi Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion
    William E Berger
    Southern California Research, Mission Viejo, California 92691, USA
    Ann Allergy Asthma Immunol 89:485-91. 2002
    ..A nonsedating antihistamine that significantly decreases nasal congestion and improves symptoms of seasonal allergic asthma would be a significant advance in therapy...
  6. ncbi Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis
    Nancy C Santanello
    Merck Research Laboratories, Rahway, New Jersey, USA
    Allergy Asthma Proc 27:231-9. 2006
    ..Sleep quality questions measure aspects of SAR that are not captured by daytime SAR symptoms. The results show that the NSS is a valid and relevant clinical measure of the impact of nighttime sleep disturbance on AR patients...